T2-low asthma presents unique challenges due to the absence of eosinophils and immunoglobulin E (IgE), which complicates both ...

Researchers gathered real-world data on biologic therapy to determine the feasibility of targeting clinical remission when ...

A recent novel study published in the New England Journal of Medicine found that Depemokimab can reduce asthma exacerbations ...

The first-in class medicine for severe asthma co-developed by AstraZeneca and Amgen is poised for accelerated approval after the US Food and Drug Administration granted it a breakthrough designation.

AstraZeneca's first-in-class severe asthma therapy Tezspire has been approved in the EU in a new pen injector formulation suitable for administration by patients themselves. The green light for ...

By Ben Jealous Not long after her adopted twins came to live with her in Freeport, Texas, Melanie Oldham saw their health ...

The changing atmosphere and dryness in the air can aggravate asthma symptoms Read this article to know how to treat it ...

Study objectives: To document the existence and investigate the etiology of "thunderstorm asthma," which has been reported sporadically over the past 20 years. Design: We assessed the relationship ...

Severe thunderstorms can be quite localised and can develop ... Never shelter under small groups of (or single) trees. The Bureau doesn't issue thunderstorm asthma warnings. Check with your state or ...

Dec. 25, 2024 — A new method of scanning lungs is able to show in real time how air moves in and out of the lungs as people take a breath in patients with asthma, chronic obstructive pulmonary ...

HC Wainwright upgraded Aclaris Therapeutics (ACRS) to Buy with a $20 price target. Aclaris gains after licensing agreement ...

From the street they’re easy to miss. But in the self-proclaimed “American Dream City” — famous for its roller coasters and ...